netFormulary NHS
Calderdale and Huddersfield
NHS Foundation Trust
Formulary
 Search
 Formulary Chapter 13: Skin - Full Chapter
13.05.03  Expand sub section  Drugs affecting the immune response
Adalimumab (Humira®)
(Dermatology)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
High Cost Medicine
 
Link  NICE TA392: Adalimumab for treating moderate to severe hidradenitis suppurativa
   
Cytotoxic Drug Azathioprine
(Dermatology)
View adult BNF View SPC online View childrens BNF
Formulary  
   
Ciclosporin
(Dermatology)
View adult BNF View SPC online View childrens BNF
Formulary  
   
Etanercept (Enbrel®)
(Dermatology)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
High Cost Medicine
 
Link  NICE TA103: Psoriasis - efalizumab and etanercept
   
Infliximab (Remicade®)
(Dermatology)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
High Cost Medicine
 
Link  NICE TA134: Infliximab for psoriasis
   
Cytotoxic Drug Methotrexate
(Dermatology)
View adult BNF View SPC online View childrens BNF
Formulary  
   
Pimecrolimus (Elidel®)
View adult BNF View SPC online View childrens BNF
Formulary  
Link  NICE TA82: Pimecrolimus and tacrolimus for atopic dermatitis (eczema)
   
Tacrolimus (Protopic®)
View adult BNF View SPC online View childrens BNF
Formulary
Tacrolimus ointment (Protopic): reminder of a possible risk of malignancies including lymphomas and skin cancers - Drug Safety Update - June 2012 Healthcare professionals are reminded that topically applied tacrolimus (Protopic) may be associated with a possible increased risk of malignancy. Protopic must not be used in patients aged younger than 2 years, and only the lower strength 0.03% version may be used in children aged 2 - 16 years. Drug Safety Update - June 2012
 
Link  NICE TA82: Pimecrolimus and tacrolimus for atopic dermatitis (eczema)
   
Ustekinumab
(Stelara)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
High Cost Medicine
 
Link  NICE TA180: Psoriasis - ustekinumab
Link  NICE TA340: Ustekinumab for treating active psoriatic arthritis
Link  NICE TA455 : Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young peopl
Link  NICE TA456 : Ustekinumab for moderately to severely active Crohn’s disease after previous treatment
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
Homecare
Homecare

Traffic Light Status Information

Status Description

Red

RED - HOSPITAL PRESCRIBING ONLY   

Amber

AMBER - SHARED CARE AGREEMENT   

Green

GREEN  

Green SI

GREEN SPECIALIST INITIATION  

netFormulary